X-8732036-T-C
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000216.4(ANOS1):c.1A>G(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000116 in 862,259 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000216.4 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD4 exome AF: 0.00000116 AC: 1AN: 862259Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 262115
GnomAD4 genome Cov.: 24
ClinVar
Submissions by phenotype
Hypogonadotropic hypogonadism 1 with or without anosmia Pathogenic:1
- -
ANOS1-related disorder Pathogenic:1
The ANOS1 c.1A>G variant is predicted to disrupt the translation initiation site (p.Met1?). This variant was previously reported in the hemizygous state in individuals with congenital hypogonadotropic hypogonadism/Kallmann syndrome (see, for example, Nair et al. 2016. PubMed ID: 26708526, figure 1, family 2; Amato et al. 2019. PubMed ID: 31200363). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at